West Total Current Liabilities from 2010 to 2024
WST Stock | USD 363.43 5.95 1.66% |
Total Current Liabilities | First Reported 1985-12-31 | Previous Quarter 671.8 M | Current Value 648.4 M | Quarterly Volatility 149.4 M |
Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West main balance sheet or income statement drivers, such as Depreciation And Amortization of 144.2 M, Total Revenue of 3.1 B or Gross Profit of 1.2 B, as well as many exotic indicators such as Price To Sales Ratio of 9.31, Dividend Yield of 0.0021 or PTB Ratio of 9.54. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
West | Total Current Liabilities |
Latest West Pharmaceutical's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of West Pharmaceutical Services over the last few years. Total Current Liabilities is an item on West Pharmaceutical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of West Pharmaceutical Services are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. West Pharmaceutical's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in West Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
Timeline |
West Total Current Liabilities Regression Statistics
Arithmetic Mean | 364,299,333 | |
Geometric Mean | 291,593,927 | |
Coefficient Of Variation | 52.59 | |
Mean Deviation | 156,292,444 | |
Median | 283,700,000 | |
Standard Deviation | 191,590,825 | |
Sample Variance | 36707T | |
Range | 689.1M | |
R-Value | 0.91 | |
Mean Square Error | 6530T | |
R-Squared | 0.83 | |
Slope | 39,142,964 | |
Total Sum of Squares | 513898.6T |
West Total Current Liabilities History
About West Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include West Pharmaceutical income statement, its balance sheet, and the statement of cash flows. West Pharmaceutical investors use historical funamental indicators, such as West Pharmaceutical's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may use each financial statement separately, they are all related. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on West Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on West Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in West Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Current Liabilities | 671.8 M | 705.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
CRM | Salesforce | |
GOOG | Alphabet Inc Class C |
Check out the analysis of West Pharmaceutical Correlation against competitors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for West Stock analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is West Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of West Pharmaceutical. If investors know West will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.78 | Earnings Share 7.58 | Revenue Per Share 39.549 | Quarterly Revenue Growth (0.03) |
The market value of West Pharmaceutical is measured differently than its book value, which is the value of West that is recorded on the company's balance sheet. Investors also form their own opinion of West Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is West Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because West Pharmaceutical's market value can be influenced by many factors that don't directly affect West Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, West Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.